Document is current

Any future updates will be listed below

Endokrine Therapie bei HR+ HER2- Mammakarzinom in der Postmenopause

Crossref DOI link: https://doi.org/10.1007/s15013-022-5092-7

Published Online: 2022-12-07

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark